Limited technological breakthroughs and low per capita income in emerging nations and underdeveloped countries impede the growth and development of the Exoskeleton Market. Companies in less developed countries confront a number of difficulties, including a lack of funding and patient access to these cutting-edge products. For instance, access to rehabilitation therapies for communities of people with disabilities has been hampered by inadequate healthcare services in emerging nations. Additionally, these developing nations rely largely on medical device imports, which raises the cost of these products and limits access, impeding the expansion and development of the exoskeleton market.
For More details, watch Video- https://lumen5.com/user/poojasalve/exoskeleton-market-n5jca/
